MoneyWorks4Me

Nectar Lifesciences informs about press release

08 Jul 2025 Evaluate

Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Nectar Lifesciences has informed that it enclosed a Press Release issued by the Company titled ‘Nectar Lifesciences Announces Strategic Sale of API and Formulations Business to Ceph Lifesciences for ?1,270 Crores’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1844.00
Dr. Reddys Labs. 1212.00
Cipla 1381.00
Lupin 2120.10
Zydus Lifesciences 1161.00
View more..